An F.D.A. panel endorses Merck’s Covid pill for high-risk adults. by BY REBECCA ROBBINS AND CARL ZIMMER


The drug, molnupiravir, could be authorized within days for patients at high risk of severe illness.

Published: November 30, 2021 at 11:10AM

from NYT Health https://ift.tt/3E5iiI1